{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"inherited-acute-myeloid-leukemia","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Inherited acute myeloid leukemia (AML) is a rare, malignant hematopologic disease characterized by clonal proliferation of myeloid blasts, primarily involving the bone marrow, in association with congenital disorders (e.g. Fanconi anemia, dyskeratosis congenita, Bloom syndrome, Down syndrome, congenital neutropenia, neurofibromatosis, etc.) and genetic defects predisposing to AML. Patients present with signs and symptoms related to ineffective hematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement (gingivitis, splenomegaly, etc.). Depending on the underlying genetic defect, there may be additional cancer risks and other health problems present.","mondoId":"MONDO:0017893","node":{"canonicalSlug":"inherited-acute-myeloid-leukemia","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Inherited acute myeloid leukemia","originalSourceId":"ORPHA:319465","paragraphs":["Inherited acute myeloid leukemia (AML) is a rare, malignant hematopologic disease characterized by clonal proliferation of myeloid blasts, primarily involving the bone marrow, in association with congenital disorders (e.g. Fanconi anemia, dyskeratosis congenita, Bloom syndrome, Down syndrome, congenital neutropenia, neurofibromatosis, etc.) and genetic defects predisposing to AML. Patients present with signs and symptoms related to ineffective hematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement (gingivitis, splenomegaly, etc.). Depending on the underlying genetic defect, there may be additional cancer risks and other health problems present."],"rawAttribution":"MONDO:0017893","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:24Z","upstream":"ORPHA:319465","url":"https://rarediseases.info.nih.gov/diseases/17450"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"acute myeloid leukemia","mondoId":"MONDO:0018874","slug":"cytogenetically-normal-acute-myeloid-leukemia"},{"kind":"parent","label":"hereditary disorder of connective tissue","mondoId":"MONDO:0023603","slug":null},{"kind":"child","label":"acute promyelocytic leukemia","mondoId":"MONDO:0012883","slug":"acute-promyelocytic-leukemia"},{"kind":"child","label":"mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)","mondoId":"MONDO:0035639","slug":null},{"kind":"child","label":"mixed phenotype acute leukemia with t(v;11q23.3)","mondoId":"MONDO:0035642","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17450\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017893\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:319465</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Inherited acute myeloid leukemia (AML) is a rare, malignant hematopologic disease characterized by clonal proliferation of myeloid blasts, primarily involving the bone marrow, in association with congenital disorders (e.g. Fanconi anemia, dyskeratosis congenita, Bloom syndrome, Down syndrome, congenital neutropenia, neurofibromatosis, etc.) and genetic defects predisposing to AML. Patients present with signs and symptoms related to ineffective hematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement (gingivitis, splenomegaly, etc.). Depending on the underlying genetic defect, there may be additional cancer risks and other health problems present.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17450\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"inherited-acute-myeloid-leukemia","sourceDocuments":[{"name":"GARD: Inherited acute myeloid leukemia","reviewed":null,"source_release":"2026-10-25T03:42:24Z","url":"https://rarediseases.info.nih.gov/diseases/17450"},{"name":"MONDO: inherited acute myeloid leukemia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0017893"}],"sourceNote":"","synonyms":["familial AML","hereditary acute myeloid leukaemia","hereditary acute myeloid leukemia","inherited AML","Pure familial acute myeloid leukaemia","Pure familial acute myeloid leukemia","Pure familial AML"],"takeawayHtml":"","title":"inherited acute myeloid leukemia"},"schemaVersion":1}
